Stocks have been more volatile around earnings than they are historically. The drops after misses have been worse than usual.

Wall Street delivered stronger than expected capital markets results for the fourth quarter, setting the stage for a solid ...

Bio, Inc. (THRD) has experienced a notable downturn, touching a 52-week low of $5.58. This latest price point reflects a significant retreat from more favorable positions over the past year, with the ...